• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,237.99 -160.73
( -0.21%)
Global Indices
Nasdaq
49,543.85 -540.61
(-1.08%)
Dow Jones
7,428.26 -93.98
(-1.25%)
Hang Seng
61,141.50 -1,512.55
(-2.41%)
Nikkei 225
10,172.40 -200.53
(-1.93%)
Forex
USD-INR
95.71 0.07
(0.07%)
EUR-INR
111.93 -0.13
(-0.12%)
GBP-INR
129.01 -0.31
(-0.24%)
JPY-INR
0.61 0.00
(-0.09%)

EQUITY - MARKET SCREENER

Welcure Drugs & Pharmaceuticals Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
524661
INE331C01025
1.0860857
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
1
35.84
EPS(TTM)
Face Value()
Div & Yield %
0.29
1
0
 

Board of AAVAS Financiers approves change in Managing Director and CEO
Apr 20,2026
The board of AAVAS Financiers at its meeting held on 20 April 2026 has approved the following change in directorate:

1. Taken note of, and accepted, the resignation of Sachinderpalsingh Jitendrasingh Bhinder (DIN:08697657) from the position of Managing Director & Chief Executive Officer of the Company, with effect from close of business hours on 20 April 2026.

2. Approved the appointment of Manu Yeshpal Singh as the Managing Director (subject to receipt of approval from the Reserve Bank of India and approval of the shareholders of the Company) & Chief Executive Officer of the Company, with effect from 21 April 2026.